RUA Life Sciences PLC

AOHA

Company Profile

  • Business description

    RUA Life Sciences PLC is engaged in contract design and manufacture of medical devices and exploiting the value of its IP and know-how, and developing of cardiovascular devices. Its segments include Biomaterials includes Licensor of Elast-Eon polymers to the medical device industry; Medical Devices and Components engages End-to-end contract developer, manufacturer, and seller of medical devices and implantable fabric specialist; Vascular engages in the development and commercialization of the group’s Elast-Eon sealed Vascular Graft products; and Structural Heart engages in the development of the group’s Elast-Eon composite heart valve material AurTex. Geographically it operates in Europe, North America, Middle East , Asia Pacific, and Africa.

  • Contact

    2 Drummond Crescent
    Ayrshire
    Scotland
    IrvineKA11 5AN
    GBR

    T: +44 1294317073

    E: [email protected]

    https://www.rualifesciences.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 March 2026

    Employees

    40

Stocks News & Analysis

stocks

Chart of the Week: We see opportunity in Mineral Resources despite debt concerns

Shares trade at a discount despite attractive longer-term outlook.
stocks

The ultimate investing hack: dividend growth stocks

Finding companies built for lasting dividend growth.
stocks

Is the data centre party over for Goodman?

Global spending spree on data centres could mean a declining return on invested capital.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,887.5029.00-0.33%
CAC 408,087.4212.810.16%
DAX 4023,693.7117.15-0.07%
Dow JONES (US)47,882.90408.440.86%
FTSE 1009,692.079.73-0.10%
HKSE25,760.73334.32-1.28%
NASDAQ23,454.0940.420.17%
Nikkei 22550,223.34358.660.72%
NZX 50 Index13,485.8696.68-0.71%
S&P 5006,849.7220.350.30%
S&P/ASX 2008,591.4027.40-0.32%
SSE Composite Index3,878.0019.71-0.51%

Market Movers